The Valley Desk

NCT04396860 · Interventional trial

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Overall registry status Completed

Phase 2 · Phase 3

Conditions Gliosarcoma, MGMT-Unmethylated Glioblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov